Human Alveolar Macrophages Are Deficient in PTEN

Dawn M. Flaherty, Martha M. Monick, Sara L. Hinde

Journal of Biological Chemistry · 2005 · 28 citations · 42 references

DOIFull text

Open access

Concepts

Abstract

Human alveolar macrophages play a critical role in host defense and in the development of inflammation and fibrosis in the lung. Unlike their precursor cells, blood monocytes, alveolar macrophages are long-lived and tend to be resistant to apoptotic stimuli. In this study, we examined the role of differentiation in altering baseline phosphatidylinositol (PI) 3-kinase/Akt activity. We found that differentiation increased activity of pro-survival PI 3-kinase/Akt while decreasing amounts of the negative PI 3-kinase regulator, PTEN. PTEN is a lipid phosphatase with activity against phosphatidylinositol 3,4,5-trisphosphate (PI3,4,5P3), the major bioactive product of PI 3-kinase. Examining in vivo differentiation of alveolar macrophages (by comparing blood monocytes to alveolar macrophages from single donors), we found that differentiation resulted in increased baseline reactive oxygen species (ROS) in the alveolar macrophages. This led to a deficiency in PTEN, increased activity of Akt, and prolonged survival of alveolar macrophages. These data support the hypothesis that alterations in ROS levels contribute to macrophage homeostasis by altering the balance between PI 3-kinase/Akt and the phosphatase, PTEN. Human alveolar macrophages play a critical role in host defense and in the development of inflammation and fibrosis in the lung. Unlike their precursor cells, blood monocytes, alveolar macrophages are long-lived and tend to be resistant to apoptotic stimuli. In this study, we examined the role of differentiation in altering baseline phosphatidylinositol (PI) 3-kinase/Akt activity. We found that differentiation increased activity of pro-survival PI 3-kinase/Akt while decreasing amounts of the negative PI 3-kinase regulator, PTEN. PTEN is a lipid phosphatase with activity against phosphatidylinositol 3,4,5-trisphosphate (PI3,4,5P3), the major bioactive product of PI 3-kinase. Examining in vivo differentiation of alveolar macrophages (by comparing blood monocytes to alveolar macrophages from single donors), we found that differentiation resulted in increased baseline reactive oxygen species (ROS) in the alveolar macrophages. This led to a deficiency in PTEN, increased activity of Akt, and prolonged survival of alveolar macrophages. These data support the hypothesis that alterations in ROS levels contribute to macrophage homeostasis by altering the balance between PI 3-kinase/Akt and the phosphatase, PTEN. Alveolar macrophages are critical effector cells in immunity and inflammation in the lung. They are derived from peripheral blood monocytes that migrate to the lung and differentiate into alveolar macrophages. Unlike their precursor cells, blood monocytes, which undergo rapid apoptosis, alveolar macrophages are long-lived and tend to be resistant to apoptotic stimuli (1Cline M.J. Lehrer R.I. Territo M.C. Golde D.W. Ann. Intern. Med. 1978; 88: 78-88Crossref PubMed Scopus (84) Google Scholar). An important cell survival pathway (and the focus of this study) is the phosphatidylinositol (PI) 2The abbreviations used are: PI, phosphatidylinositol; ROS, reactive oxygen species; PI3,4,5P3, phosphatidylinositol 3,4,5-trisphosphate; DMPO, 5,5-dimethyl-1-pyrroline N-oxide; NAC, N-acetylcysteine; XIAP, X-chromosome-linked inhibitor of apoptosis; ERK, extracellular signal-regulated kinase; PPARγ, peroxisome proliferator-activated receptor γ; GFP, green fluorescent protein; PTEN, phosphatase and tensin homologue deleted on chromosome 10; Ad, adenovirus; HPRT, hypoxanthine-guanine phosphoribosyltransferase. 3-kinase/Akt pathway. PI 3-kinase phosphorylates membrane phospholipids, generating phosphatidylinositol 3,4,5-trisphosphate (PI3,4,5P3). PH domain proteins, including Akt, are recruited to PI3,4,5P3 in the plasma membrane, leading to their activation. Akt modulates cell survival by both up-regulating pro-survival pathways and down-regulating pro-apoptotic pathways (2Toker A. Mol. Pharmacol. 2000; 57: 652-658Crossref PubMed Scopus (284) Google Scholar, 3Cantley L.C. Science. 2002; 296: 1655-1657Crossref PubMed Scopus (4681) Google Scholar). Akt activity is negatively regulated by the lipid phosphatase, PTEN. PTEN dephosphorylates PI3,4,5P3, reducing the pool of phosphoinositides required for Akt activity (4Cantley L.C. Neel B.G. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 4240-4245Crossref PubMed Scopus (1754) Google Scholar). PTEN was originally described as a tumor suppressor protein and is deleted or mutated in a number of malignancies; however, it has become clear in numerous studies that PTEN also serves an important role in the regulation of normal cellular functions, including development, immunity, and cell growth (for review, see Ref. 5Yamada K.M. Araki M. J. Cell Sci. 2001; 114: 2375-2382Crossref PubMed Google Scholar). Regulation of PTEN has been shown to occur at several levels. Phosphorylation of PTEN results in a conformational change in the protein and masking of the membrane binding surface, thus preventing interaction of PTEN with its membrane-localized substrate, PI3,4,5P3 (6Das S. Dixon J.E. Cho W. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 7491-7496Crossref PubMed Scopus (283) Google Scholar, 7Vazquez F. Ramaswamy S. Nakamura N. Sellers W.R. Mol. Cell. Biol. 2000; 20: 5010-5018Crossref PubMed Scopus (656) Google Scholar, 8Vazquez F. Sellers W.R. Biochim. Biophys. Acta. 2000; 1470: M21-M35PubMed Google Scholar). Oxidant-mediated negative regulation of PTEN function has also been shown to occur (9Lee S.R. Yang K.S. Kwon J. Lee C. Jeong W. Rhee S.G. J. Biol. Chem. 2002; 277: 20336-20342Abstract Full Text Full Text PDF PubMed Scopus (849) Google Scholar), resulting in reversible inactivation of PTEN phosphatase activity. PTEN has also been shown to be regulated transcriptionally (10Patel L. Pass I. Coxon P. Downes C.P. Smith S.A. Macphee C.H. Curr. Biol. 2001; 11: 764-768Abstract Full Text Full Text PDF PubMed Scopus (329) Google Scholar, 11Stambolic V. MacPherson D. Sas D. Lin Y. Snow B. Jang Y. Benchimol S. Mak T.W. Mol. Cell. 2001; 8: 317-325Abstract Full Text Full Text PDF PubMed Scopus (752) Google Scholar, 12Virolle T. Adamson E.D. Baron V. Birle D. Mercola D. Mustelin T. de Belle I. Nat. Cell Biol. 2001; 3: 1124-1128Crossref PubMed Scopus (354) Google Scholar, 13Vasudevan K.M. Gurumurthy S. Rangnekar V.M. Mol. Cell. Biol. 2004; 24: 1007-1021Crossref PubMed Scopus (222) Google Scholar) and via alterations in protein stability (7Vazquez F. Ramaswamy S. Nakamura N. Sellers W.R. Mol. Cell. Biol. 2000; 20: 5010-5018Crossref PubMed Scopus (656) Google Scholar, 14Torres J. Pulido R. J. Biol. Chem. 2001; 276: 993-998Abstract Full Text Full Text PDF PubMed Scopus (534) Google Scholar). Our studies demonstrate that alveolar macrophages are deficient in PTEN and that this is linked to constitutive activation of Akt. Differentiation-induced increases in baseline ROS contribute to the decreased PTEN protein and increased Akt observed in alveolar macrophages. Reagents—Chemicals were obtained from Sigma-Aldrich. The PI 3-kinase inhibitor LY294002 was obtained from Calbiochem. Protease inhibitors were obtained from Roche Diagnostics (Mannheim, Germany). Antibodies were from various sources: anti-PTEN antibodies were from Cascade Biosciences (Winchester, MA), antibodies to phosphorylated Akt (serine 473) and cleaved caspase 7 were from Cell Signaling Technology (Beverly, MA), the antibody to β-actin was from Sigma-Aldrich, and antibodies to total Akt were from Santa Cruz Biotechnology (Santa Cruz, CA). Secondary antibodies for Western analysis (horseradish peroxidase-conjugated anti-rabbit or -mouse Ig) were also from Santa Cruz Biotechnology. Isolation of Human Alveolar Macrophages—Alveolar macrophages were obtained from bronchoalveolar lavage as previously described (15Monick M.M. Carter A.B. Hunninghake G.W. J. Biol. Chem. 1999; 274: 18075-18080Abstract Full Text Full Text PDF PubMed Scopus (52) Google Scholar). Briefly, normal volunteers with a lifetime non-smoking history, no acute or chronic illness, and no current medications, with the exception of oral contraceptives, underwent bronchoalveolar lavage. The lavage procedure used five 20-ml aliquots of sterile, warmed saline in each of three segments of the lung. The lavage fluid was filtered through two layers of gauze and centrifuged at 1500 × g for 5 min. The cell pellet was washed twice in saline and suspended in complete medium, Rosewell Park Memorial Institute tissue culture medium (Invitrogen) with gentamicin. Differential cell counts were determined using a Wright-Giemsa-stained cytocentrifuge preparation. All cell preparations had between 90 and 100% alveolar macrophages. All protocols were approved by the University of Iowa Institutional Review Board. Isolation of Human Blood Monocytes—A volume of 180 ml of heparinized whole blood was obtained by venipuncture of the same volunteers that underwent bronchoscopy. Peripheral blood mononuclear cells were isolated over a Ficoll-Hypaque gradient (Sigma-Aldrich), and monocytes were isolated by negative selection using magnetic labeling and separation techniques (Miltenyi Biotech, Auburn, CA). Monocyte purity was evaluated using Wright-Giemsa staining and was >98%. Monocytes were differentiated in 10% human AB serum for 8-10 days at which time cells were harvested for either total protein or RNA. Cell Survival Assay—Freshly isolated alveolar macrophages were plated in serum-free media plus gentamicin alone or with the PI 3-kinase inhibitor, LY294002 (50 μm) for 24 h. Samples were analyzed for cell death using two different methods: trypan blue exclusion and ethidium homodimer nuclear staining (Molecular Probes, Eugene, OR). The percentage of dead cells was calculated by counting at least 300 cells per field in a blinded fashion. Triplicate cultures were performed on each of two separate experiments. These cells were assessed for apoptosis using Western analysis and an antibody directed against cleaved caspase 7. In some experiments, cell viability was also assessed using a commercially available kit to quantitate ATP amounts (CellTiter-Glo®, Promega, Madison, WI). ATP amounts have been shown to correlate with metabolically active (viable) cells (16Crouch S.P. Kozlowski R. Slater K.J. Fletcher J. J. Immunol. Methods. 1993; 160: 81-88Crossref PubMed Scopus (740) Google Scholar). Adenovirus Vectors—First generation recombinant adenovirus was generated by the University of Iowa Gene Transfer Vector Core (17Anderson R.D. Haskell R.E. Xia 2000; PubMed Scopus Google Scholar). The of the were were × Adenovirus the for green fluorescent protein by the PTEN by J. at or an no were used to the cells at a of of These were of as determined by and isolated human alveolar macrophages were and was in serum-free The cells were at for 24 and harvested for total cellular In cell survival was determined using either ethidium homodimer staining or the ATP viability Survival of was determined in each by green of the cells using a Germany). were with the and Western analysis for the of was performed on isolated alveolar macrophages or blood monocytes using total cellular The protein of the were by the amounts of protein of nuclear and of total cellular were with 10% and were from a 10% and at for h. Cell were to with in saline with for and with the antibody for at or at The were washed and with a peroxidase-conjugated antibody and with a substrate, development of the were from the by for each at in Western and the were for An was and protein levels were using a and for analysis The data were and were performed using CA). of PTEN was from isolated human alveolar macrophages or blood monocytes using of was to using a kit and was using the kit (Molecular Probes, Eugene, OR). The resulting was to as In a was to of of each (Molecular of each and and of was performed in an data were the to that were to the generated with of the was using were and by and as a function of the at which the in a as of in over the baseline used for human PTEN and are as to PTEN were on from the for Biotechnology data and with by S. and J. and J. available at of PTEN was calculated as for each the for PTEN and were of PTEN to of in each cell was calculated by the The of this was by using of of PTEN and the the for PTEN and were found to be isolated blood monocytes and alveolar macrophages were in saline culture in serum-free media or in media plus The 5,5-dimethyl-1-pyrroline was to the at a of for were using a with the × and of were the of over min. The of the were on the of the Biol. Med. 3: PubMed Scopus Google Scholar, C. B. F. M. S. R. P. J. Med. Chem. PubMed Scopus Google Scholar). analysis was performed on the the survival and was determined by the Alveolar Akt and as with Blood studies in that alveolar macrophages have constitutive activation of Akt M.M. Carter A.B. Hunninghake G.W. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar) which is to play an important role in survival of cells J. Med. 2001; PubMed Scopus Google Scholar). that alveolar macrophages have a in vivo survival time their precursor cells, blood monocytes E.D. R.E. Golde D.W. Science. PubMed Scopus Google Scholar), we that monocytes have Akt activation. PTEN is a negative of the PI 3-kinase we that alveolar macrophages have amounts of PTEN. We obtained of isolated peripheral blood monocytes and alveolar macrophages from a of normal human isolated total cellular and performed Western analysis using antibodies directed against active Akt on 473) and total PTEN. shown in human alveolar macrophages have constitutive Akt activity with blood monocytes with a in PTEN. blood monocytes have constitutive Akt activation and amounts of PTEN. PI for Survival in Alveolar to we examined in survival of human alveolar macrophages in culture in the of the PI 3-kinase inhibitor, In experiments, macrophages were serum-free with and inhibitor, and cell death was using trypan blue exclusion and ethidium homodimer staining 24 h. results and the of PI 3-kinase activation and phosphorylated Akt on survival of We also examined survival by cells for total protein and a Western analysis for cleaved caspase 7 7 is a major in the of is a major effector caspase that and serves as a for apoptosis A. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar, M. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, S. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar). In the Western shown as an to the survival we demonstrate that PI 3-kinase activity caspase 7 with the in cell death by trypan blue exclusion and ethidium homodimer We also that blood monocytes, which levels of active Akt, are to cell death and apoptosis via of PI 3-kinase. This also the that Akt activation is critical for cell of PTEN Akt and Alveolar the of PTEN on alveolar macrophage we alveolar macrophages with an adenovirus the PTEN These data are shown in The that alveolar macrophages be with using an adenovirus The is a Western analysis of PTEN and Akt that PTEN is in cells with the PTEN is by the of PTEN results in of Akt activation and cell shown by ethidium homodimer staining and by ATP viability by Alveolar PTEN experiments, we demonstrate that differentiation of blood monocytes to alveolar macrophages to an in baseline and the to we found that alveolar with blood monocytes, amounts of reactive oxygen species in the blood monocytes or This is with a that alveolar macrophages increased with blood monocytes A.B. S. Y. Hunninghake G.W. J. Cell Mol. Biol. 2004; PubMed Scopus Google Scholar). in the led to the alterations in are linked to the in PTEN protein and have shown that PTEN be regulated by via of the proteins, K.M. Gurumurthy S. Rangnekar V.M. Mol. Cell. Biol. 2004; 24: 1007-1021Crossref PubMed Scopus (222) Google Scholar), and we have observed that alveolar macrophages have constitutive of it is that activation is N. Biol. Med. PubMed Scopus Google Scholar, R. P. J. PubMed Scopus Google Scholar) and that this activation C.H. Lee J. Biol. Chem. 2003; PubMed Scopus Google Scholar, F. A. Biol. Med. 2002; PubMed Scopus Google Scholar, Biol. Med. 2000; PubMed Scopus Google Scholar, J. C. Biol. Chem. 1999; PubMed Google Scholar, J. Immunol. Google Scholar, S. M. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). we that the of PTEN be by in macrophages. this we used the or the of to of alveolar macrophages and examined the on PTEN in macrophages. These results are shown in we determined generation of in blood monocytes and alveolar macrophages at baseline and with that alveolar monocytes, amounts of and that this is by the of the levels on PTEN we evaluated whole cell for PTEN with or and that PTEN is increased in alveolar macrophages with or that by alveolar macrophages is important in of PTEN. we performed a in blood monocytes no we found no in PTEN protein amounts with PTEN in Monocyte that human alveolar macrophages are derived from blood monocytes via a differentiation and that cells have different levels of PTEN and Akt we PTEN amounts were in Peripheral blood monocytes obtained from normal human volunteers were differentiated in culture with human serum for and or total protein was isolated from the that macrophages have decreased PTEN with the HPRT, the differentiation This is to the in baseline PTEN comparing blood monocytes to human alveolar macrophages is important to that levels of between monocytes and alveolar macrophages are Examining protein levels of PTEN the in differentiation we found a over time of amounts of PTEN we examined Akt activation in we found that active Akt increased with cell we found that differentiation to an in ROS These data that the in PTEN levels and Akt activity between blood monocytes and alveolar macrophages are the of a differentiation that be in We also examined the of of on survival of monocytes differentiated in that monocytes differentiated in the of have survival and to differentiate into This that of the of differentiation is important for the alveolar survival of the of alveolar macrophages is their to for prolonged of time in In the time of alveolar macrophages in is days E.D. R.E. Golde D.W. Science. PubMed Scopus Google Scholar). This is in to their precursor cells, blood monocytes, which have a and undergo apoptosis days (1Cline M.J. Lehrer R.I. Territo M.C. Golde D.W. Ann. Intern. Med. 1978; 88: 78-88Crossref PubMed Scopus (84) Google Scholar). are derived from peripheral blood monocytes that migrate to the lung undergo studies have the survival between alveolar macrophages and their precursor cells J. Med. 2001; PubMed Scopus Google Scholar, Mol. Cell. Biol. 2000; 20: PubMed Scopus Google Scholar, Y. C. J. 2003; PubMed Scopus Google Scholar, M.M. Carter A.B. Hunninghake G.W. J. Cell Mol. Biol. 2001; PubMed Scopus Google Scholar, M.M. M. D. S. Hunninghake G.W. J. Immunol. 2004; PubMed Scopus Google Scholar), and have examined the role of differentiation in this We have shown for the time that human alveolar macrophages are deficient in PTEN and that this with constitutive of Akt. The in PTEN be by the alveolar macrophage levels of reactive oxygen differentiation a role in the PTEN is regulated with in differentiation of PTEN, originally described as a tumor suppressor protein J. C. D. S. J. C. L. R. M. B. R. Science. PubMed Scopus Google Scholar, R.E. R. 57: Google Scholar), a role in normal cellular development and through its as a lipid phosphatase for PI3,4,5P3 (for see L.C. Neel B.G. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 4240-4245Crossref PubMed Scopus (1754) Google and 8Vazquez F. Sellers W.R. Biochim. Biophys. Acta. 2000; 1470: M21-M35PubMed Google Scholar). The of PI3,4,5P3 levels activation of Akt apoptosis to occur R. J. J. N. B. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: PubMed Scopus Google Scholar, V. A. de C. T. J. Mak T.W. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar). In PTEN is to and R. J. J. N. B. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: PubMed Scopus Google Scholar, V. A. de C. T. J. Mak T.W. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar, A. P. C. Science. 1999; PubMed Scopus Google Scholar, A. J. M. K.M. C. R. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: PubMed Scopus Google Scholar). of from PTEN that cells have increased amounts of PI3,4,5P3, constitutive of Akt, and survival in to pro-apoptotic stimuli V. A. de C. T. J. Mak T.W. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar) the of PTEN in Akt activation through its as a lipid These studies the of PTEN in development, and tumor Our studies that alterations in amounts of PTEN play a role in regulation of normal cell survival via in blood monocytes and alveolar macrophages. blood monocytes, which levels of PTEN and active Akt, undergo rapid apoptosis, alveolar active Akt and PTEN, have prolonged survival in vivo and in is PTEN regulation in normal In development in PTEN levels are increases in a of A. J. M. K.M. C. R. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: PubMed Scopus Google Scholar). PTEN to be in cells and regulated by and by on protein stability (7Vazquez F. Ramaswamy S. Nakamura N. Sellers W.R. Mol. Cell. Biol. 2000; 20: 5010-5018Crossref PubMed Scopus (656) Google Scholar, 12Virolle T. Adamson E.D. Baron V. Birle D. Mercola D. Mustelin T. de Belle I. Nat. Cell Biol. 2001; 3: 1124-1128Crossref PubMed Scopus (354) Google Scholar, M.M. T. T. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: PubMed Scopus Google Scholar, M.M. P. Yang 2000; Google Scholar). PTEN has been shown to be by T. Adamson E.D. Baron V. Birle D. Mercola D. Mustelin T. de Belle I. Nat. Cell Biol. 2001; 3: 1124-1128Crossref PubMed Scopus (354) Google Scholar), V. MacPherson D. Sas D. Lin Y. Snow B. Jang Y. Benchimol S. Mak T.W. Mol. Cell. 2001; 8: 317-325Abstract Full Text Full Text PDF PubMed Scopus (752) Google Scholar), and (10Patel L. Pass I. Coxon P. Downes C.P. Smith S.A. Macphee C.H. Curr. Biol. 2001; 11: 764-768Abstract Full Text Full Text PDF PubMed Scopus (329) Google Scholar), is negative regulation of PTEN in normal The was by K.M. Gurumurthy S. Rangnekar V.M. Mol. Cell. Biol. 2004; 24: 1007-1021Crossref PubMed Scopus (222) Google Scholar) in which examined the role of on of PTEN in and found that PTEN is regulated by via of the They a between and PTEN amounts in several tumor cell normal We have found a in human alveolar macrophages levels of and Our data that is PTEN in alveolar macrophages with blood monocytes that either PTEN is in macrophages or that PTEN is In a for the decreased PTEN and protein in alveolar we found that by alveolar macrophages in to the of PTEN. regulation of PTEN phosphatase function has been previously described (9Lee S.R. Yang K.S. Kwon J. Lee C. Jeong W. Rhee S.G. J. Biol. Chem. 2002; 277: 20336-20342Abstract Full Text Full Text PDF PubMed Scopus (849) Google Scholar, Lee C.H. Y. Yang K.S. Lee S.R. 2004; PubMed Scopus Google Scholar, D. A. Downes C.P. J. 2003; PubMed Scopus Google Scholar), is the to regulation of PTEN protein studies to this are studies have examined the resulting in prolonged survival of macrophages and the role of differentiation in the development of this The studies from and and have shown that macrophages constitutive of phosphorylated Akt for survival and that constitutive activation of Akt and are important for of the J. Med. 2001; PubMed Scopus Google Scholar, Y. C. J. 2003; PubMed Scopus Google Scholar). They have also shown that of active in a macrophage cell and in macrophages apoptosis of cells in a caspase to of the Mol. Cell. Biol. 2000; 20: PubMed Scopus Google Scholar). have shown that differentiation of macrophages results in of the proteins, XIAP, and L. A. F. P. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar, J. Y. M. B. B. J. 2003; PubMed Scopus Google Scholar), this has been in alveolar macrophages. Our has shown that activation of and Akt is required for survival of alveolar macrophages and that to survival via an on the and Akt pathways M.M. M. D. S. Hunninghake G.W. J. Immunol. 2004; PubMed Scopus Google Scholar). Our current of constitutive Akt activation and that a deficiency in PTEN to and is important for macrophage We that the of PTEN in alveolar with alterations of PTEN that occur has PTEN amounts differentiation of blood monocytes (10Patel L. Pass I. Coxon P. Downes C.P. Smith S.A. Macphee C.H. Curr. Biol. 2001; 11: 764-768Abstract Full Text Full Text PDF PubMed Scopus (329) Google Scholar). These examined the role of the nuclear receptor peroxisome proliferator-activated receptor on regulation of PTEN They found that monocytes that were differentiated in the of the had a in PTEN with a of Akt and that have a role in regulation of the PI 3-kinase pathway in In to study, found an of PTEN with total PTEN protein in the monocytes to the macrophages. These be to different of in differentiation and to time at which PTEN was These obtained at of in differentiated monocytes were harvested is alterations in PTEN are for alveolar we have examined tissue macrophages. be to are to the lung that have an on PTEN regulation in macrophages. to this are a data the that differentiation of monocytes results in macrophages with a by levels of PTEN, Akt and prolonged survival

References

42